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Abstract
Mast cells are able to trigger life-saving immune responses in murine models for acute inflammation. 
In such settings, several lines of evidence indicate that the rapid and protective recruitment of 
neutrophils initiated by the release of mast cell-derived pro-inflammatory mediators is a key 
element of innate immunity. Herein, we investigate the impact of mast cells on critical parameters 
of neutrophil effector function. In the presence of activated murine bone marrow-derived mast cells, 
neutrophils freshly isolated from bone marrow rapidly lose expression of CD62L and up-regulate 
CD11b, the latter being partly driven by mast cell-derived TNF and GM-CSF. Mast cells also strongly 
enhance neutrophil phagocytosis and generation of reactive oxygen species. All these phenomena 
partly depend on mast cell-derived TNF and to a greater extend on GM-CSF. Furthermore, 
spontaneous apoptosis of neutrophils is greatly diminished due to the ability of mast cells to 
deliver antiapoptotic GM-CSF. Finally, we show in a murine model for acute lung inflammation that 
neutrophil phagocytosis is impaired in mast cell-deficient Kit W-sh/Kit W-sh mice but can be restored 
upon mast cell engraftment. Thus, a previously underrated feature of mast cells is their ability to 
boost neutrophil effector functions in immune responses.
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Introduction
Polymorphonuclear neutrophils are the most abundant 
leukocyte population (50–70%) in the peripheral blood of 
humans and make important contributions to the innate 
host defense against pathogenic micro-organisms such 
as fungi and bacteria. They participate in the early innate 
immune response by rapidly migrating into inflamed tissue, 
where they employ their potent effector functions such as 
phagocytosis, the release of anti-microbial substances, 
reactive oxygen species (ROS) and inflammatory media-
tors. The effector functions of neutrophils are mainly medi-
ated and  regulated via cell-surface receptors (i.e. fMLP 
receptors and TLRs) (1–3). However, under inflammatory 
conditions and also in homeostasis, it is important that the 
activation and survival of neutrophils is tightly controlled 
since the release of cytotoxic substances by neutrophils 
can easily cause collateral damage of adjacent healthy 
tissue (4).
Apoptosis is an important mechanism of safely eliminating 
neutrophils during the resolution of inflammation. In paral-
lel with the activation of neutrophil effector functions, many 
inflammatory mediators also regulate cell survival by alter-
ing apoptosis (5, 6). The local control of neutrophil activation 
and survival is highly relevant for all inflammatory conditions, 
from microbial infections to sterile inflammations such as gout 
(7) or rheumatoid arthritis where neutrophils make a signifi-
cant contribution. Therefore, it is important to understand the 
underlying mechanisms to control local neutrophil activity.
With the advent of mast cell-deficient mice and selective 
engraftment with in-vitro-generated bone marrow-derived 
mast cells (BMMC), it was shown that these cells are critical 
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for the initiation of acute inflammatory responses in diverse 
experimental settings. In several models for acute inflammation 
in mice, the rapid recruitment of neutrophils turned out to be 
initiated by mast cells, which are predominantly localized at 
possible entry sites of noxious substances (8–11).
With regard to the underlying mechanisms, the influx of 
neutrophils in immune-complex-mediated peritonitis in mice 
was reported to partly depend on mast cell-derived leukot-
rienes (LT) as potent chemoattractants (12).
In addition, mast cell-derived TNF was shown to be crucial 
for the recruitment of neutrophils in this model and also in 
late-phase cutaneous anaphylaxis (13, 14), contact hyper-
sensitivity reactions (CHSR) (15), Th17 cell-dependent lung 
inflammation (16), formation of cutaneous granulomas (17), 
experimental autoimmune encephalomyelitis (18) and IL-33-
induced inflammation (19). The unique ability of mast cells to 
store and immediately release TNF on demand is essential 
for the rapid onset of inflammatory reactions (20, 21).
A cornerstone in this context was the observation that mast 
cells and mast cell-derived TNF initiate the life-saving influx 
of neutrophils in mouse models for acute bacterial infections 
(22, 23). In murine infectious peritonitis, it was published that 
besides TNF, mast cell-derived LT, mouse mast cell protease 
6 and the chemokine macrophage inflammatory protein 2 
(MIP-2) MIP-2 are critical for a rapid and protective influx 
of neutrophils (24–27). In a murine model for CHSR, it was 
shown that mast cell-derived TNF acts on TNFRI-expressing 
endothelial cells mediating the recruitment of neutrophils 
to sites of inflammation (28). In addition, mast cell-derived 
MIP-2 acts synergistically with TNF by establishing a chemot-
actic gradient for neutrophil extravasation and migration (15). 
The ability of mast cells to participate in innate immunity is 
based on the expression of a host of receptors leading to the 
activation of these cells independently of IgE, including most 
TLRs and complement receptors (29, 30).
Herein, we investigate the impact of murine BMMC and mast-
cell-derived TNF and GM-CSF on critical effector functions of 
freshly isolated neutrophils. Activated BMMC modulate the 
expression of activation markers on neutrophils, trigger genera-
tion of ROS, promote phagocytosis and reduce spontaneous 
apoptosis. Importantly, in mast cell-deficient mice, neutrophil 
phagocytosis is impaired in a model for acute lung inflammation.
Methods
Mice
Genetically mast cell-deficient Kit W-sh/Kit W-sh mice on a 
C57BL/6 background (31–33) were initially obtained by 
Marcus Maurer (Department of Dermatology, Charite, 
Berlin, Germany). Mice deficient for TNF (34) were kindly 
provided by Kerstin Steinbrink (Department of Dermatology, 
Mainz, Germany). TNF-deficient animals were adequately 
backcrossed to the C57BL/6 strain and have been used as 
bone marrow and mast cell donors in several of our prior 
publications (35, 36). Mice deficient for GM-CSF (37) on 
a C57BL/6 background were provided by L.C. (Institute 
of Experimental Immunology, Zürich, Switzerland). Animal 
procedures were conducted in accordance with the institu-
tional guidelines.
Generation and activation of BMMC and reconstitution of 
mast cell-deficient mice
BMMC were generated from bone marrow according to 
standard procedures (38). For stimulation via their FcεRI 
receptors, BMMC were sensitized with the IgE anti-DNP Ab 
A2 for 48–72 h (39), washed and then cross-linked using 
plate-bound 2,4-dinitrophenyl human serum albumin (DNP-
HSA)  (2.5  μg ml−1; Sigma-Aldrich, Seelze, Germany) for 
24 h. Kit W-sh/Kit W-sh mice were systemically given intravenous 
injections of 5 × 106 BMMC for at least 12 weeks before the 
experiments were conducted. To assess reconstitution effi-
ciencies, lungs were fixed by inflation (1 ml), immersed in 
4% formalin or Carnoy’s solution and embedded in paraf-
fin. Tissue sections were used for metachromatic mast cell 
stainings with toluidine blue (40). Slides were examined 
in a blinded fashion with a microscope (BX40; Olympus, 
Hamburg, Germany). For the assessment for mast cell num-
bers in each slide, mast cells were counted by a blinded 
investigator in five different fields and in each field the lung 
area was measured using an image analysis system (Soft 
Imaging System; Olympus). Numbers of mast cells are 
expressed per square centimeter.
Flow cytometric analyses
Flow cytometry studies were performed on FACSCanto and 
LSR II analyzer running FACSDiva software (BD, Heidelberg, 
Germany).
Isolation and activation of neutrophils
The Ly-6Ghigh-expressing granulocyte subpopulation was 
isolated from bone marrow by positive selection magnetic 
cell separation (MACS) using the Miltenyi Biotec mouse Anti-
Ly-6G MicroBead Kit according to the manufacturer’s instruc-
tions (Miltenyi, Bergisch Gladbach, Germany). The purity of 
the isolated cells was at least 96% according to the expres-
sion of Gr-1 and CD11b.
Neutrophil receptor expression was determined by flow 
cytometry using fluorochrome-conjugated monoclonal 
antibodies.
2.5 × 105 neutrophils were incubated with 100 ng ml−1 LPS 
(Escherichia coli serotype 055:B5, Sigma-Aldrich) or with 
2.5 × 105 activated mast cells or mast cell-conditioned super-
natants. After 5 h, the stimulation was stopped by washing 
cells with ice-cold FACS buffer (PBS + 0.5% BSA + 0.1% 
NaN3). Then, cells were re-suspended in FACS buffer with 
added antibodies and incubated at 4°C for 15 min. The panel 
of monoclonal antibodies (eBioscience, Frankfurt, Germany) 
was PE-Cy7 anti-CD11b (clone M1/70), FITC anti-CD62L 
(clone MEL-14), APC anti-Gr-1 (clone RB6-8C5) and anti-
CD16/CD32 (clone 93). Cells were washed twice with cold 
FACS buffer and were immediately analyzed using flow cytom-
etry. Results are expressed as normalized geometric mean of 
fluorescence intensity on unstimulated neutrophils, which is 
a quantitative reflection of the number of CD11b or CD62L 
subset present on Ly-6G-positive cells.
ROS assessment
The amount of intracellular ROS was identified by flow cytom-
etry using 2',7'-dichlorofluorescein diacetate (DCFH-DA; 
Sigma-Aldrich).
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When applied on the cells, the non-ionic, non-polar, color-
less DCFH-DA crosses cell membranes and is hydrolyzed 
enzymatically by intracellular esterases to non-fluorescent 
DCFH. In the presence of ROS, DCFH is oxidized to highly 
fluorescent dichlorofluorescein (DCF) (41). Therefore, intra-
cellular DCF fluorescence can be used as an index to quan-
tify the overall ROS in cells.
2.5 × 105 neutrophils were incubated with 0.5  µM fMLP 
(Merck, Darmstadt, Germany) or with previously generated 
supernatant from 2.5 × 105 mast cells activated overnight. 
After defined time points, the experiment was stopped by 
washing cells with ice-cold FACS buffer (PBS + 0.5% BSA). 
Then, cells were re-suspended in FACS buffer with APC 
anti-Gr-1 (clone RB6-8C5), anti-CD16/CD32 (clone 93)  and 
5  µM DCFH-DA, and incubated at room temperature for 
20 min avoiding direct light. Cells were washed twice with 
ice-cold FACS buffer and were immediately analyzed by flow 
cytometry. Results are expressed as normalized geometric 
mean of fluorescence intensity on unstimulated neutrophils.
In vitro phagocytosis assay
Neutrophil phagocytosis was quantified by ingestion of 
PC red fluorescent polystyrene microspheres (diameter 
1  µm; Fluoresbrite® polychromatic red microspheres; 
Polysciences, Eppelheim, Germany). Microspheres were 
opsonized with 20 µg ml−1 IgG mouse antihuman antibody 
(clone 4C9) for 1 h at 37°C and subsequently were washed 
three times with PBS.
Aliquots of 0.25 × 106 freshly purified neutrophils were pre-
incubated with supernatants from BMMC or with BMMC in 
co-culture in IMDM supplemented with 5% FCS (inactivated 
at 56°C) for 2 h at 37°C. Then, cells were incubated with 
microspheres (1  µl of suspension with 4.55 × 1010 particles 
per milliliter) for 30–45 min at 37°C. Cells were harvested and 
washed three times in cold FACS buffer. After staining with 
APC-conjugated anti-Gr-1 (clone RB6-8C5; BD) and PE-Cy7-
labeled anti-CD11b (clone M1/70; eBioscience), cells were 
fixed with Cytofix (BD) and analyzed by FACS (Canto II; BD).
In vivo phagocytosis assay and bronchoalveolar lavage
Mice were anesthetized (Ketamin-ratiopharm®/Rompun 2%; 
Ratiopharm, Ulm, Germany) and challenged intra-nasally 
with 1 µg LPS in combination with 1.5 × 108 IgG-opsonized 
PC red fluorescent polystyrene microspheres. Eight hours 
later, animals were sacrificed and lungs were lavaged via the 
tracheal tube with PBS (1 ml). Numbers of bronchoalveolar 
lavage (BAL) cells were counted by trypan blue dye exclu-
sion. Cells were then stained, fixed in 1% paraformaldehyde 
in PBS and analyzed by FACS.
Annexin V and propidium iodide apoptosis assays
Aliquots of 0.25 × 106 freshly purified neutrophils were incu-
bated with supernatants from BMMC or with BMMC in co-
culture for 20–24 h at 37°C. Cells were harvested and stained 
with APC-conjugated anti-Gr-1 (clone RB6-8C5; BD). After 
washing twice in PBS, cells were stained with FITC-labeled 
Annexin V according to the manufacturer’s instructions (BD). 
Cells were stained with 50  µg ml−1 propidium iodide (PI; 
Sigma Aldrich) and immediately analyzed by FACS.
Alternatively, DNA fragmentation was measured by flow-
cytometric analysis of PI-stained nuclei (42).
Results
Mast cells modulate the expression of activation markers on 
neutrophils and trigger neutrophil oxidative burst
In order to investigate the influence of mast cells on neutro-
phil effector functions, we established a co-culture system 
using Ly-6G-positive MACS-purified neutrophils from murine 
bone marrow and in-vitro-generated BMMC. Prior to the onset 
of the experiments, BMMC were sensitized with monoclonal 
anti-DNP IgE. In co-culture with freshly isolated neutrophils, 
BMMC were activated upon cross-linking of IgE with the 
antigen, DNP-HSA. In pilot experiments, it was confirmed 
that neutrophils do not respond to either IgE-loaded BMMC 
or their supernatants or to the antigen, DNP-HSA (data not 
shown).
As depicted in Fig. 1, we first analyzed the expression of 
the activation markers CD11b and CD62L on the neutrophil 
surface using FACS analyses. Freshly isolated resting neutro-
phils and neutrophils activated by LPS in a range from 1 to 
1000 ng ml−1 served as references. According to the expecta-
tions, resting neutrophils constitutively express intermediate 
levels of CD11b and high levels of CD62L on their surface, 
and the expression of both molecules is inversely regulated 
by LPS. Activation of neutrophils is accompanied by the rapid 
translocation of CD11b from latent intracellular granule-asso-
ciated stores to the plasma membrane, whereas CD62L is 
down-regulated by shedding (43). Compared with untreated 
neutrophils, the expression levels of CD11b and CD62L are 
unimpaired in the presence of mast cells loaded with IgE but 
dramatically altered upon cross-linking of IgE with the respec-
tive antigen. Relative changes in the expression of both mol-
ecules following activation of mast cells exceed the effects 
of LPS on neutrophils, which was used as a positive control.
Modulation of CD11b and CD62L surface expression can 
also be achieved using culture supernatants from activated 
BMMC, implying that soluble mast cell mediators are mainly 
responsible for this phenomenon. Pro-inflammatory stimuli are 
known activators of neutrophil function and mast cell-derived 
TNF has already been shown to exert pleiotropic effects on 
different cell types and inflammatory responses (30). For 
this reason, we included mast cells derived from TNF- and 
GM-CSF-deficient mice in our studies. It can be concluded 
from the data shown in Fig. 1 that mast cell-derived TNF is 
partly, but not solely, responsible for this mast cell-mediated 
increase in CD11b expression, whereas TNF has hardly any 
effect on down-regulation of CD62L.
Conversely, up-regulation of CD11b on neutrophils is com-
pletely abrogated using conditioned medium derived from 
activated GM-CSF-deficient BMMC although lack of this 
cytokine does not impair the decrease of CD62L. It should 
be noted that all the effects of mast cell derived cytokines on 
neutrophils described herein were also verified using recom-
binant TNF and GM-CSF (data not shown).
Along the same line, we examined the ability of neutrophils 
to mediate an oxidative burst, a key event for the elimina-
tion of invading and ingested micro-organisms. Activation of 
the NADPH oxidase complex leads to the generation of ROS 
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including H2O2, which can be measured using the fluores-
cent dye DCF (44). On the basis of our observations shown 
above, we used conditioned medium from BMMC in order to 
investigate the impact of mast cells on the generation of ROS 
by neutrophils.
In Fig.  2A, incubation of neutrophils with supernatants 
derived from activated wild-type BMMC leads to a strong 
production of intracellular ROS seen as a rapid and 
transient increase in fluorescence intensities. As a positive 
control for these kind of experiments, we chose fMLP, a 
known activator of ROS generation, in concentrations 
ranging from 0.25 to 2 μM (Fig. 2B). However, the impact of 
mast cells on the generation of ROS equals that of fMLP at 
the highest concentrations (1 and 2 μM) and the oxidative 
burst initiated by mast cell-derived supernatants appears 
more sustained compared with fMLP. Furthermore, it can 
be seen that the oxidative burst mainly depends on mast 
cell-derived GM-CSF and although to a lesser extent 
on TNF.
Mast cells prolong the survival of neutrophils
In order to investigate the impact of mast cells on sponta-
neous apoptosis of neutrophils, we incubated neutrophils in 
the presence of conditioned medium derived from activated 
BMMC (Fig.  3). Following 24 h incubation of neutrophils in 
medium, more than 40% of the cells bind annexin V, a sign for 
early apoptosis. A minor fraction of late apoptotic cells is in 
addition also positive for PI staining. The addition of superna-
tant derived from wild-type BMMC activated by cross-linking 
of IgE substantially decreases spontaneous apoptosis of 
neutrophils (Fig. 3A and B). However, the antiapoptotic effect 
is completely abrogated using supernatants from GM-CSF-
deficient BMMC (Fig. 3C and D). In contrast to this striking 
impact of mast cell-derived GM-CSF, TNF-deficient BMMC do 
not alter spontaneous neutrophil apoptosis (Fig. 3A and B). 
In these experiments, supernatants derived from IgE-loaded 
BMMC without cross-linking by antigen had no effect on neu-
trophil apoptosis (data not shown).
To support these findings, we also measured the DNA con-
tent in PI-stained neutrophil nuclei. As depicted in Fig.  3E, 
following 48-h incubation of neutrophils in medium, 50% of 
nuclei appear as a broad hypodiploid peak. The presence of 
conditioned medium derived from either activated wild-type 
or TNF-deficient mast cells strongly reduces the number of 
hypodiploid nuclei. Yet, supernatant from GM-CSF-deficient 
BMMC has hardly any effect on DNA fragmentation. Thus, 
both methods independently show that mast cell-derived 
GM-CSF can strongly delay the apoptosis of neutrophils.
Neutrophil phagocytosis is enhanced by mast cells
Ingestion and killing of microbes is a key element of neu-
trophil function. Thus, we next analyzed the ability of mast 
cells to promote neutrophil phagocytosis. This process can 
be quantitatively assessed by measuring the uptake of flu-
orescent polystyrene microspheres as depicted in Fig.  4. 
Without additional activation, about one-third of neutrophils 
take up beads, yet the relatively low fluorescence intensities 
indicate that most cells ingest only a very small number of 
beads (Fig. 4A). In the presence of LPS, both the numbers 
of cells that have taken up beads and their fluorescence 
Fig. 1. Activated mast cells modulate the expression of activation markers on neutrophils. Freshly isolated neutrophils were incubated in 
co-culture in a ratio of 1:1 with IgE-loaded or IgE-loaded and cross-linked BMMC from wild-type mice. Additionally, neutrophils were treated 
with conditioned medium (50 vol%) derived from either activated wild-type BMMC (supernatant wt) or BMMC deficient for TNF or GM-CSF, 
respectively. Freshly isolated neutrophils and neutrophils treated with increasing doses of LPS served as references. After 5 h, CD62L and 
CD11b expression was measured by FACS as geometric mean fluorescence intensities. High expression of CD62L and constitutive low-level 
expression of CD11b on freshly isolated neutrophils were set to 1, respectively. Shown are the means (+ standard deviation) from at least three 
experiments. * indicates P < 0.05 and *** P < 0.001 as determined by one-way analysis of variance implemented in the Prism 5.0 software. 
n. s., not significant.
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intensities strongly increase. However, phagocytosis can be 
further increased using supernatants derived from activated 
BMMC. Under these conditions, almost all neutrophils are 
loaded with numerous beads. In the absence of mast cell-
derived TNF, the percentage of bead-positive neutrophils 
remains unchanged, yet the number of ingested particles 
per cell decreases (Fig.  4B). Finally, the lack of mast cell-
derived GM-CSF leads to a strong decrease of both param-
eters. However, even in the absence of GM-CSF, the residual 
effect of mast cell-conditioned medium on neutrophil phago-
cytosis is still comparable with LPS. The enhancement of par-
ticle uptake is a very strong effect as displayed in Fig.  4C 
where conditioned medium derived from activated mast cells 
was diluted. Even at a dilution of 1:32, particle engulfment 
is significantly elevated above untreated levels. Additionally, 
we also varied the ratio of BMMC:neutrophils in co-culture 
experiments and got comparable results. At a ratio of 1:32, 
neutrophil particle uptake was still significantly increased 
(data not shown).
Thus, activated mast cells strongly boost neutrophil phago-
cytosis and it appears likely that, besides TNF and GM-CSF, 
other mast cell-derived mediators are able to promote this 
process.
Fig. 2. Activated mast cells initiate the generation of ROS in neu-
trophils. (A) Intracellular ROS generation in neutrophils was ana-
lyzed by flow cytometry at the indicated time points following 
addition of conditioned mast cell medium derived from the geno-
types described above. 0.5 μM fMLP was included as a reference. 
(B) Different concentrations of fMLP were used and the generation 
of ROS was recorded. Shown are the means (± SD) from three 
experiments. Mean fluorescence intensity of freshly isolated rest-
ing neutrophils was arbitrarily set to 1.  * indicates P  <  0.05 as 
determined by one-way analysis of variance implemented in the 
Prism 5.0 software.
Fig. 3. Mast cells prolong the survival of neutrophils.(A) Freshly iso-
lated neutrophils were incubated for 24 h with or without additional 
conditioned medium (50 vol%) derived from activated TNF-deficient 
BMMC or their congenic littermates. Spontaneous apoptosis was 
measured using staining with PI and annexin V. (B) Means (+ standard 
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Mast cells boost neutrophil phagocytosis in a model for 
acute lung inflammation
In order to investigate whether mast cells also boost the func-
tion of neutrophils in vivo, we chose a model of LPS-induced 
acute lung inflammation. Besides wild-type and mast cell-
deficient Kit W-sh/Kit W-sh mice, mast cell-deficient mice were 
also engrafted with BMMC derived from wild-type, TNF- and 
GM-CSF-deficient mice 12 weeks prior to the experiment. 
Successful engraftment of Kit W-sh/Kit W-sh mice was ensured 
by staining lung sections derived from all animal groups for 
the presence of mast cells (Fig. 5, lower panel).
For the induction of pulmonar inflammation, LPS was 
given intra-nasally in combination with fluorescent polysty-
rene microspheres. Eight hours later, cellular infiltrates were 
recovered by lavage of the lungs and analyzed for the pres-
ence of neutrophils. As depicted in Fig.  5 (upper panel), 
application of LPS induces a strong influx of neutrophils into 
the lungs, which is comparable in all experimental groups. 
This mast cell-independent recruitment of neutrophils is 
most likely due to the fact that in the lungs different cell 
types, including structural cells, express TLR4 and are able 
to initiate an innate immune response (45). Phagocytosis 
of fluorescent beads by neutrophils can be visualized by 
FACS (Fig. 5, middle panel). Most importantly, the absence 
of mast cells is accompanied by a reduction in neutrophil 
phagocytosis, measured as a drop in fluorescence intensi-
ties. This reduction in neutrophil phagocytosis can be cor-
rected through the selective repair of mast cell-deficiency 
with mast cells derived from wild-type or TNF-deficient mice. 
Obviously, the observed effect of mast cell-derived TNF on 
neutrophil phagocytosis in vitro (Fig. 4) can be compensated 
for by additional sources for TNF in the lungs, most likely 
bronchiolar epithelial cells and alveolar macrophages (46). 
This assumption is supported by our observation that TNF 
levels in BAL do not significantly differ between mast cell-
deficient and wild-type mice at 8 h after application of LPS 
(data not shown).
However, engraftment of sash mice with GM-CSF-deficient 
BMMC is insufficient to restore neutrophil phagocytosis, indi-
cating that mast cells serve as a non-redundant source for 
this cytokine in this model. Unfortunately, we were not able 
to measure GM-CSF in BAL using ELISA. In summary, this 
result corroborates our data generated in vitro and empha-
sizes the influence of mast cells on neutrophil phagocytosis 
in vivo.
Discussion
It is increasingly being recognized that mast cells are able 
to induce and to regulate inflammatory responses in diverse 
experimental settings. These cells are strategically located 
Fig. 4. Neutrophil phagocytosis is enhanced by mast cells. (A) Neutrophils were incubated for 2 h with PE-labeled microspheres under the con-
ditions shown, washed and FACS analyzed for the uptake of fluorescent particles. (B) Means (+ SD) of three experiments like the representative 
shown in (A). (C) Neutrophils were treated as described above but only conditioned medium derived from activated wild-type mast cells was 
diluted as indicated. Means (± standard deviation) from three experiments. *** P < 0.001; n. s., not significant.
deviation) from four experiments like the one shown before. (C) 
Performed as described above but to investigate the effect of 
GM-CSF-deficient BMMC on neutrophil apoptosis. (D) Means (+ 
standard deviation) of three experiments. (E) Neutrophils were 
treated as described in (A) but incubated for 48 h. Following PI stain-
ing, apoptotic nuclei appear as a broad smear of low fluorescence 
intensity. Means (± SD) from three experiments are given. ** P < 0.01; 
*** P < 0.001; n. s., not significant.
Mast cells boost neutrophil effector functions 559
at the borders between host and environment, that is skin 
and mucosal surfaces, and can rapidly respond to a vari-
ety of stimuli even in the absence of IgE antibodies (30, 47). 
Activation of mast cells can promote the rapid recruitment of 
neutrophils that are able to combat harmful intruders using 
oxidative and non-oxidative mechanisms but these pro-
cesses can also play a key role in the development of inflam-
matory and autoimmune diseases (48). Further, in the context 
of intercellular communication, recent studies revealed a 
bidirectional cross-talk between mast cells and eosinophils, 
termed the allergic effector unit, augmenting the activation of 
both cells (49, 50).
Our observations reported herein demonstrate that mast 
cells are able to boost important effector functions of neu-
trophils, that is phagocytosis and generation of ROS. This is 
partly due to the de novo production of TNF and GM-CSF, 
whereas histamine, which is rapidly released from granu-
lar stores, had no effect on neutrophils (data not shown). It 
was reported that mast cells are able to store TNF that can 
be released rapidly upon stimulation, but it should be noted 
that BMMC used for the experiments described herein and 
other mast cell lines do not contain preformed TNF (20). 
It has been known for a long time that mast cells are able 
to produce GM-CSF (51) and our results show prominent 
effects of mast cell-derived GM-CSF on all parameters of 
neutrophil activity examined including its strong antiapop-
totic action. A variety of inflammatory signals can extend the 
lifespan of neutrophils. TNF is also known to regulate neu-
trophil apoptosis but opposing effects have been reported 
in that it can either accelerate or delay programmed cell 
death, depending on the concentration. High concentrations 
of TNF promote apoptosis, whereas low concentrations are 
antiapoptotic. This dual effect of TNF is likely due to differen-
tial effects on the antiapoptotic pathways in neutrophils, that 
is accelerated turnover of the antiapoptotic protein Mcl-1 at 
high concentrations and increased expression of another 
antiapoptotic molecule, BFL-1, at low concentrations of this 
cytokine (52).
However, in our in vitro system, mast cell-derived GM-CSF 
is solely responsible for delaying apoptosis of neutrophils. 
This antiapoptotic effect of mast cells might support efficient 
anti-microbial activity in inflamed tissues.
Besides mast cell-derived cytokines, we have good evi-
dence that mast cell-derived lipid mediators also strongly 
promote the activation of neutrophils (data not shown) but 
additional work is needed to identify these lipids.
To corroborate our in vitro findings, we used a model for 
acute lung inflammation following instillation of LPS. Inhalation 
of LPS leads to the rapid recruitment of neutrophils and also 
activates mast cells (53, 54). In agreement with another 
report (16), we found that LPS-induced airway neutrophilia 
is not influenced by the lack of mast cells but importantly, 
the ability of neutrophils to phagocytose is impaired in the 
absence of mast cells.Fig.  5. Mast cells promote neutrophil phagocytosis in a model for 
acute lung inflammation. One microgram LPS in combination with 
1.5 × 108 fluorescent polystyrene microspheres were applied intra-
nasally in anesthetized mice of the indicated groups. Eight hours later, 
BAL was recovered and neutrophils were counted (upper panel). 
FACS analyses were performed to quantify neutrophils that have 
undergone phagocytosis of PE-labeled microspheres. Geometric 
mean fluorescence intensities (MFI) are shown. * indicates P < 0.05 
and *** P < 0.001 as determined by unpaired t-test implemented in 
the Prism 5.0 software (middle panel). Lung sections were stained 
for the presence of mast cells using toluidine blue (lower panel). 
Representative of at least two experiments with 4–5 mice per group.
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Taken together, our results suggest that mast cells are 
involved in the local control of neutrophil activation and sur-
vival and thus could have important implications for the role of 
mast cells in innate immunity but also in allergic and autoim-
mune diseases.
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